TY - JOUR
T1 - Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPARα
AU - Kanemitsu, Takumi
AU - Tsurudome, Yuya
AU - Kusunose, Naoki
AU - Oda, Masayuki
AU - Matsunaga, Naoya
AU - Koyanagi, Satoru
AU - Ohdo, Shigehiro
N1 - Funding Information:
This work was supported in part by KAKENHI Grant-in-aid for Scientific Research 16H02636 and 17H06262 from the Japan Society for the Promo-tion of Science (JSPS) (to S. O.). The authors declare that they have no con-flicts of interest with the contents of this article.
Funding Information:
This work was supported in part by KAKENHI Grant-in-aid for Scientific Research 16H02636 and 17H06262 from the Japan Society for the Promotion of Science (JSPS) (to S. O.). The authors declare that they have no conflicts of interest with the contents of this article.
Publisher Copyright:
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2017/12/29
Y1 - 2017/12/29
N2 - Xanthine oxidase (XOD), also known as xanthine dehydrogenase, is a rate-limiting enzyme in purine nucleotide degradation, which produces uric acid. Uric acid concentrations in the blood and liver exhibit circadian oscillations in both humans and rodents; however, the underlying mechanisms remain unclear. Here, we demonstrate that XOD expression and enzymatic activity exhibit circadian oscillations in the mouse liver. We found that the orphan nuclear receptor peroxisome proliferator-activated receptor-α (PPARα) transcriptionally activated the mouse XOD gene and that bile acids suppressed XOD transactivation. The synthesis of bile acids is known to be under the control of the circadian clock, and we observed that the time-dependent accumulation of bile acids in hepatic cells interfered with the recruitment of the co-transcriptional activator p300 to PPARα, thereby repressing XOD expression. This time-dependent suppression of PPARα-mediated transactivation by bile acids caused an oscillation in the hepatic expression of XOD, which, in turn, led to circadian alterations in uric acid production. Finally, we also demonstrated that the anti-hyperuricemic effect of the XOD inhibitor febuxostat was enhanced by administering it at the time of day before hepatic XOD activity increased. These results suggest an underlying mechanism for the circadian alterations in uric acid production and also underscore the importance of selecting an appropriate time of day for administering XOD inhibitors.
AB - Xanthine oxidase (XOD), also known as xanthine dehydrogenase, is a rate-limiting enzyme in purine nucleotide degradation, which produces uric acid. Uric acid concentrations in the blood and liver exhibit circadian oscillations in both humans and rodents; however, the underlying mechanisms remain unclear. Here, we demonstrate that XOD expression and enzymatic activity exhibit circadian oscillations in the mouse liver. We found that the orphan nuclear receptor peroxisome proliferator-activated receptor-α (PPARα) transcriptionally activated the mouse XOD gene and that bile acids suppressed XOD transactivation. The synthesis of bile acids is known to be under the control of the circadian clock, and we observed that the time-dependent accumulation of bile acids in hepatic cells interfered with the recruitment of the co-transcriptional activator p300 to PPARα, thereby repressing XOD expression. This time-dependent suppression of PPARα-mediated transactivation by bile acids caused an oscillation in the hepatic expression of XOD, which, in turn, led to circadian alterations in uric acid production. Finally, we also demonstrated that the anti-hyperuricemic effect of the XOD inhibitor febuxostat was enhanced by administering it at the time of day before hepatic XOD activity increased. These results suggest an underlying mechanism for the circadian alterations in uric acid production and also underscore the importance of selecting an appropriate time of day for administering XOD inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=85039762340&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039762340&partnerID=8YFLogxK
U2 - 10.1074/jbc.M117.791285
DO - 10.1074/jbc.M117.791285
M3 - Article
C2 - 29101234
AN - SCOPUS:85039762340
SN - 0021-9258
VL - 292
SP - 21397
EP - 21406
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 52
ER -